Bessi et al. used an NSG panel targeting 6 selected genes (B2M, STAT6, XPO1, NFKBIE, PTPN1, and TNFAIP3) to compare the mutational spectrum of matched tissue biopsies and plasma collected before treatment in 24 cHL patients. The gene discussed is PTPN1; the disease is classic Hodgkin lymphoma.